CzeekV インデックス 活用事例・実践,研究報告など、お役立ち情報をシェアします

論文・技術情報追加のお知らせ

• 論文・技術情報追加のお知らせ

  2025年5月11日～2025年5月17日の間に収集した論文情報を追加しました。

  1. Signal mining and analysis of adverse events of Brentuximab Vedotin base on FAERS and JADER databases.

  BVに関連する予期せぬ有害事象を検出

  対象DB：FAERS,JADER

  2. Drug-induced second tumors: a disproportionality analysis of the FAERS database.

  新薬含む二次がんリスクをFAERSで検出

  対象DB：FAERS

  3. Improved Pharmacovigilance Signal Detection Using Bayesian Generalized Linear Mixed Models.

  AEの構造を考慮した新モデルでワクチン安全性解析

  対象DB：FAERS,VAERS

  4. Drug-induced cardiac arrest: a pharmacovigilance study from 2004-2024 based on FAERS database.

  40超の薬剤で心停止リスク上昇を確認

  対象DB：FAERS

  5. Drug-associated infections and infestations in older adults with tumor necrosis factor-alpha inhibitors: a real-world retrospective and pharmacovigilance study.

  高齢者TNF阻害薬は感染リスク増、特に結核注意

  対象DB：FAERS

  6. Post-marketing safety of anakinra and canakinumab: a real-world pharmacovigilance study based on FDA adverse event reporting system.

  IL-1阻害薬アナキンラとカナキヌマブは注射部位反応や感染が主な副作用

  対象DB：FAERS

  7. Safety Profile of Amantadine: A Comprehensive Analysis of Real-World Adverse Events from the FDA Adverse Event Reporting System Database.

  アマンタジンは神経精神系副作用が多く、高齢女性に注意が必要

  対象DB：FAERS

  8. Drug-Associated Pemphigus Reported by Physicians: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System.

  医師報告の薬剤性天疱瘡をFAERSで解析

  対象DB：FAERS

  9. Multidimensional Assessment of Psychiatric Adverse Events Related to Proton Pump Inhibitors: A Real-World, Pharmacovigilance Study.

  PPIは精神副作用と遺伝的関連あり

  対象DB：FAERS

  10. Proton pump inhibitors use and risk of type 2 diabetes mellitus: correlation analysis, prediction model construction, and key genes identification.

  PPI使用はT2DMリスク上昇と関連、AGT・JAK2関与

  対象DB：FAERS

  11. A pharmacovigilance analysis of post-marketing safety of durvalumab.

  デュルバルマブで新規有害事象報告、特に高齢男性

  対象DB：FAERS

  12. Nephrotoxicity of direct factor Xa inhibitors: a pharmacovigilance study using real-world data from the Federal Adverse Event Reporting System database.

  FXa阻害薬で腎毒性リスク、特にエドキサバン

  対象DB：FAERS

  13. Antiplatelet-Proton Pump Inhibitor Interactions and Arterial Thrombotic Events: A Pharmacovigilance Assessment Using Disproportionality and Interaction Analysis.

  クロピドグレルとPPI併用で血栓リスク増

  対象DB：FAERS

  14. Adverse drug events associated with insulin glargine: a real-world pharmacovigilance study based on the FAERS database.

  インスリングラルギンに新たな副作用シグナル

  対象DB：FAERS

  15. Post-marketing safety concerns with pirfenidone and nintedanib: an analysis of individual case safety reports from the FDA adverse event reporting system database and the Japanese adverse drug event report databases.

  ピルフェニドンとニンテダニブで副作用に差

  対象DB：FAERS,JADER

  16. Age-related adverse effects of Tamoxifen in female breast cancer patients: Insights from the FDA's adverse event reporting system.

  タモキシフェンの副作用は加齢で増加

  対象DB：FAERS

  17. Cardiovascular safety of Janus kinase inhibitors: A pharmacovigilance study from 2012-2023.

  JAK阻害薬に心血管リスク、慎重な監視を

  対象DB：FAERS

  18. Adverse Events Associated with Apremilast and Deucravacitinib for Psoriasis: A Pharmacovigilance Study Based on the FAERS Database.

  皮膚・消化器AEsに性差、慎重な使用を

  対象DB：FAERS

  19. Thrombotic adverse events associated with TNF-alpha blockers: a real-world pharmacovigilance analysis of the FAERS database.

  TNF阻害薬は血栓リスクと関連、特に産後に注意

  対象DB：FAERS

  20. Suicidal thoughts and behaviors associated with fluoroquinolone antibiotics: a real-world pharmacovigilance analysis.

  フルオロキノロンは全体で自殺念慮のシグナルなし

  対象DB：FAERS

  21. The Cardiac and Renal Safety of Semaglutide in Patients with Type 2 Diabetes: A Real-World Study Based on FAERS.

  セマグルチドは糖尿病患者で腎心臓安全性に問題なし

  対象DB：FAERS

  22. Women and adverse drug reactions: 56 years of analysis of real-world data collected in the FDA adverse event reporting system (FAERS) database.

  FAERSデータで女性の副作用リスクを56年分析

  対象DB：FAERS

  23. Delirium risk associated with Esketamine, Sevoflurane, Propofol, and Dexmedetomidine: A Real-World Study Based on the FDA Adverse Event Reporting System.

  プロポフォールら3薬でせん妄リスク増加

  対象DB：FAERS

  24. Post-Marketing Safety of Spinal Muscular Atrophy Therapies: Analysis of Spontaneous Adverse Drug Reactions from EudraVigilance.

  SMA治療薬の安全性を市販後報告で評価

  対象DB：EudraVigilance

  25. Argatroban plus Dual Antiplatelet Therapy versus Dual Antiplatelet Alone for Acute Atherothrombotic Cerebral Infarction.

  DAPT＋アルガトロバンの有効性は同等

  対象DB：DPC

  26. Trends and outcomes of chemotherapy timing in critically ill patients with hematologic malignancies using a Japanese national database.

  ICU中の化学療法は一定の生存率を維持

  対象DB：DPC

  27. Treatment Persistence of Paliperidone Palmitate 3-Month in Patients With Schizophrenia: A Japan Medical Data Center Claims Database Analysis.

  PP3Mの1年持続率は約77%と高率

  対象DB：JMDC

  28. Characteristics of people with severe mental illness excluded from incentivised physical health checks in the UK: electronic healthcare record study.

  SMI患者の健康診断除外は約28%

  対象DB：CPRD

  29. Developing prediction models for electrolyte abnormalities in patients indicated for antihypertensive therapy: evidence-based treatment and monitoring recommendations.

  電解質異常予測モデルは臨床応用可能

  対象DB：CPRD

  30. Evaluating prediction of short-term tolerability of five type 2 diabetes drug classes using routine clinical features: UK population-based study.

  中止予測モデルは精度低く臨床有用性乏しい

  対象DB：CPRD

  31. Antimicrobial Resistance Trends, Predictors, and Burden in England: A retrospective study using the Clinical Practice Research Datalink from 2015-2021.

  AMR感染は医療費・死亡率を大幅増加

  対象DB：CPRD

  32. Medications used for seizure-emergency management in the UK community: A clinical practice research datalink retrospective database study.

  緊急発作薬使用者は7%、受診頻度高い

  対象DB：CPRD

  33. Incretin-Based Drugs and the Incidence of Endometrial Cancer Among People with Type 2 Diabetes: Active Comparator New-User Design.

  GLP-1製剤とDPP-4阻害薬で子宮癌リスク増加

  対象DB：CPRD

  タグ:

  • お知らせ
  • 論文

• お問合わせ

  お問合わせ

  検索

  サイト内検索・論文検索

  

  検索

  サイト内 論文

  キーワード

  PubmedID
  Abstract
  Title
  Journal
  Date (PubMed追加日)	～
  Author
  タクソノミー検索	タクソノミー検索 CAERS CARD CPRD CVAR CVARD DeSC DPC EHR EudraVigilance FAERS Fibroblasts FPVD GPRD Ionizing JADER JMDC KAERS KIDS-KAERS KIDS-KD MDV NDB Nickel Pharmacoepidemiology Radiation RWE THIN Unknown VAERS VigiBase インフォメーション スコア値 スコア指標 総合ランキング 閾値

  

  メルマガ登録

  購読申し込み